Financial Calendar

POXEL (Euronext - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and NASH, announces its schedule for the publication of financial information for 2018.

Event Date*
2017 Q4 Financial Update January 22, 2018
2017 Full Year Financial Statement March 22, 2018
2018 Q1 Financial Update April 23, 2018
2018 Q2 Financial Update July 10, 2018
2018 First Half Financial Statement September 19, 2018
2018 Q3 Financial Update October 16, 2018
2018 Q4 Financial Update February 12, 2019

*Subject to modification.